Serum-associated inhibition of leukotaxis in humans with cancer.
about
Decreased T lymphocyte migration in patients with malignancy mediated by a suppressor cell populationRecovery of uncommon bacteria from blood: association with neoplastic diseaseIn vitro monocyte maturation in squamous carcinoma of the lung.In vitro monocyte maturation in squamous-cell carcinoma of the lung: influence of humoral factors.Serum inhibitory effect on myeloperoxidase in human cancerRestoration by ketoprofen of defective neutrophil granulocyte migration induced in guinea-pigs by plasma from cancer patients.In vitro and in vivo production of chemotactic inhibitors by tumor cells.Suppression of macrophage oxidative metabolism by products of malignant and nonmalignant cells.Microbiology and management of infected solid tumours.Effect of a factor released by K562 malignant cells in culture on human neutrophil bactericidal activityInhibitors of monocyte responses to chemotaxins are present in human cancerous effusions and react with monoclonal antibodies to the P15(E) structural protein of retroviruses.Suppression of acute and chronic inflammation in tumor-bearing rats.Polymorphonuclear neutrophils and cancer: intense and sustained neutrophilia as a treatment against solid tumors.Impairment of neutrophil chemotaxis by serum from patients with chronic lymphoproliferative diseaseInfluence of BCG administration time on the in-vivo migration of leukocytes.Neutrophil function during chemotherapy for Hodgkin's disease.Enhancement of polymorphonuclear leukocyte-mediated tumor cytotoxicity by serum factor(s).
P2860
Q34607846-D7C262F5-3606-4EE7-A3A6-4F770506B152Q35535042-6D8256E2-928B-454D-BB9B-C1E34875FFD6Q36045114-0B46431E-F57B-4EAB-97A8-FB64652D640FQ36046363-3D2D42B3-1175-4441-9D1A-5DA97C9B8C74Q36089623-4C2B6A02-AE7A-4875-A375-9A6748D13EAEQ36091333-DAC0BC80-C17C-460E-A564-6497B2F729D2Q36092770-D0052A8D-1B9C-4D10-8B49-90E29F16344CQ36346940-86759A31-6180-4F02-A909-1C15AD359807Q36709615-EE9BDF88-E24A-4D0F-AEC2-4787B14C03F7Q36967011-ED16EAC2-DD6B-4DF9-84A7-B3AF8A9C772DQ37003829-FB4E9F88-CF1F-4ED7-801E-D6C323DBE0AEQ37039930-B54FE5B8-654E-4B9C-BD70-F288AF272FACQ37646545-2C11F6DA-52DB-45C9-9B11-FF764D15D817Q39508606-D32E9127-78C7-4258-9876-E53D883F1CBCQ41431315-60C50E05-16CD-4D39-ADF7-3499C7E5C6F2Q41493811-77A0FD74-519C-48F1-88CC-C3697F8E7F0CQ55363462-E314D933-4B1B-46C6-8D6E-E412DF66CBB4
P2860
Serum-associated inhibition of leukotaxis in humans with cancer.
description
1978 nî lūn-bûn
@nan
1978年の論文
@ja
1978年学术文章
@wuu
1978年学术文章
@zh-cn
1978年学术文章
@zh-hans
1978年学术文章
@zh-my
1978年学术文章
@zh-sg
1978年學術文章
@yue
1978年學術文章
@zh
1978年學術文章
@zh-hant
name
Serum-associated inhibition of leukotaxis in humans with cancer.
@en
type
label
Serum-associated inhibition of leukotaxis in humans with cancer.
@en
prefLabel
Serum-associated inhibition of leukotaxis in humans with cancer.
@en
P1476
Serum-associated inhibition of leukotaxis in humans with cancer.
@en
P2093
P304
P356
10.1016/0090-1229(78)90068-5
P577
1978-02-01T00:00:00Z